Travere Therapeutics shares owned by MPM Oncology Impact Management
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by MPM Oncology Impact Management
from 13F filings
Historical chart of MPM Oncology Impact Management investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by MPM Oncology Impact Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $4.9M | 553k | 8.94 |
| 2023-06-30 | $8.5M | 553k | 15.36 |
| 2023-03-31 | $7.1M | 314k | 22.49 |
| 2022-12-31 | $5.9M | 282k | 21.03 |
| 2022-09-30 | $6.8M | 277k | 24.64 |
| 2022-06-30 | $6.7M | 278k | 24.23 |
| 2022-03-31 | $7.2M | 278k | 25.77 |
| 2021-12-31 | $8.9M | 288k | 31.04 |
| 2021-09-30 | $7.4M | 307k | 24.25 |
More positions owned by MPM Oncology Impact Management
View all positions for MPM Oncology Impact Management